Related Experiment Video
Updated: Jun 23, 2026
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Thrombolysis: adjuvant therapy and the role of complement
1Cardiovascular Research Unit, Edinburgh, U.K.
European Heart Journal
|August 1, 1990
Summary
Adjuvant therapy after thrombolysis may reduce myocardial stunning and necrosis by preventing reperfusion injury. Understanding injury mechanisms, including complement
Area of Science:
- Cardiovascular Medicine
- Ischemia-Reperfusion Biology
Background:
- Thrombolysis for myocardial infarction can lead to reperfusion injury, causing 'stunned myocardium' and potentially necrosis.
- The extent of myocardial damage after ischemia and reperfusion is not fully understood.
- Mechanisms of injury and repair, particularly the role of complement, are key to understanding myocardial stunning.
Purpose of the Study:
- To investigate the potential role of adjuvant therapy in mitigating reperfusion injury following thrombolysis.
- To determine if preventing reperfusion injury can reduce myocardial stunning and necrosis.
- To explore whether modifying reperfusion injury favorably impacts clinical outcomes.
Main Methods:
- Review of existing literature on ischemia-reperfusion injury and myocardial stunning.
- Identification of key mediators involved in myocardial damage and repair.
- Analysis of the role of complement in the context of coronary artery thrombus lysis and reperfusion.
Main Results:
- Reperfusion injury and stunned myocardium are significant concerns after thrombolysis.
- Complement activation plays a central role in the inflammatory response to reperfusion.
- Interventions targeting reperfusion injury mechanisms are being explored.
Conclusions:
- Adjuvant therapy following thrombolysis holds potential for reducing myocardial stunning and necrosis.
- A deeper understanding of ischemia-reperfusion mechanisms is essential for developing effective interventions.
- Further research is needed to confirm the clinical benefits of modifying reperfusion injury.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...